Junichiro Sageshima

Dr. Junichiro Sageshima

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2012 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
THT. Hibi
T. Hibi
JSJunichiro Sageshima
Junichiro Sageshima
EME. Molina
E. Molina
GCG. Ciancio
G. Ciancio
SNS. Nishida
S. Nishida
GBG. W. Burke
G. W. Burke
Since the adoption of the Model for End‐Stage Liver Disease, simultaneous liver/kidney transplants (SLKT) have substantially increased. Recently, unfavorable outcomes have been reported yet contributing factors remain unclear. We retrospectively reviewed 74 consecutive adult SLKT performed at our center from 2000 to 2010 and compared with kidney transplant alone (KTA, N = 544). In SLKT, patient and death‐censored kidney graft survival rates were 64 ± 6% and 81 ± 5% at 5 years, respectively (median follow‐up, 47 months). Multivariable analyses revealed three independent risk factors affecting patient survival: hepatitis C virus positive (HCV+, hazard ratio [HR] 2.9, 95% confidence interval [CI] 1.1–7.9), panel reactive antibody (PRA) > 20% (HR 2.8, 95% CI 1.1–7.2) and female donor gender (HR 2.9, 95% CI 1.1–7.9). For death‐censored kidney graft survival, delayed graft function was the strongest negative predictor (HR 8.3, 95% CI 2.5–27.9), followed by HCV+ and PRA > 20%. The adjusted risk of death‐censored kidney graft loss in HCV+ SLKT patients was 5.8 (95% CI 1.6–21.6) compared with HCV+ KTA (p = 0.008). Recurrent HCV within 1 year after SLKT correlated with early kidney graft failure (p = 0.004). Careful donor/recipient selection and innovative approaches for HCV+ SLKT patients are critical to further improve long‐term outcomes.

1 September 2011 in Transplant Immunology
Verified
Journal Article
Closed access
JSJunichiro Sageshima
Junichiro Sageshima
GCGaetano Ciancio
Gaetano Ciancio
GGGiselle Guerra
Giselle Guerra
JGJeffrey J. Gaynor
Jeffrey J. Gaynor
DCDeborah Cova
Deborah Cova
GBGeorge W. Burke
George W. Burke

12 August 2016 in Transplant International
Verified
Journal Article
Closed access
PDF file
SPSiegfredo Paloyo
Siegfredo Paloyo
JSJunichiro Sageshima
Junichiro Sageshima
JGJeffrey J. Gaynor
Jeffrey J. Gaynor
LCLinda Chen
Linda Chen
GCGaetano Ciancio
Gaetano Ciancio
GBGeorge W. Burke
George W. Burke
Kidney grafts are often preserved initially in static cold storage (CS) and subsequently on hypothermic machine perfusion (MP). However, the impact of CS/MP time on transplant outcome remains unclear. We evaluated the effect of prolonged CS/MP time in a single-center retrospective cohort of 59 donation after circulatory death (DCD) and 177 matched donation after brain death (DBD) kidney-alone transplant recipients. With mean overall CS/MP times of 6.0 h/30.0 h, overall incidence of delayed graft function (DGF) was higher in DCD transplants (30.5%) than DBD transplants (7.3%, P < 0.0001). In logistic regression, DCD recipient (P < 0.0001), longer CS time (P = 0.0002), male recipient (P = 0.02), and longer MP time (P = 0.08) were associated with higher DGF incidence. In evaluating the joint effects of donor type (DBD vs. DCD), CS time (<6 vs. ≥6 h), and MP time (<36 vs. ≥36 h) on DGF incidence, one clearly sees an unfavorable effect of MP time ≥36 h (P = 0.003) across each donor type and CS time stratum, whereas the unfavorable effect of CS time ≥6 h (P = 0.01) is primarily seen among DCD recipients. Prolonged cold ischemia time had no unfavorable effect on renal function or graft survival at 12mo post-transplant. Long CS/MP time detrimentally affects early DCD/DBD kidney transplant outcome when grafts were mainly preserved by MP; prolonged CS time before MP has a particularly negative impact in DCD kidney transplantation.

1 June 2014 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
JSJunichiro Sageshima
Junichiro Sageshima
GCGaetano Ciancio
Gaetano Ciancio
LCLinda Chen
Linda Chen
TDTakehiko Dohi
Takehiko Dohi
AEAshraf El‐Hinnawi
Ashraf El‐Hinnawi
GBGeorge W. Burke
George W. Burke

26 January 2020 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
GFGhaneh Fananapazir
Ghaneh Fananapazir
GTGary Tse
Gary Tse
RGRyan Di Geronimo
Ryan Di Geronimo
JMJohn McVicar
John McVicar
RPRichard Perez
Richard Perez
CTChristoph Troppmann
Christoph Troppmann
Pediatric en bloc kidney transplants (EBKs) from small deceased pediatric donors are associated with increased early graft loss and morbidity. Yet, urologic complications post‐EBK and their potential impact on graft survival have not been systematically studied. We retrospectively studied urological complications requiring intervention for 225 EBKs performed at our center 01/2005‐09/2017 from donors ≤20 kg into recipients ≥18 years. Overall ureteral complication incidence after EBK was 9.8% (n=22) (12% vs. 2% for EBK donors <10 kg vs. ≥ 10 kg, respectively [p=0.031]). The most common post‐EBK urologic complication was a stricture (55%), followed by urine leak (41%). In all, 95% of all urologic complications occurred early within 5 months posttransplant (median, 138 days). Urologic complications could be successfully managed nonoperatively in 50% of all cases and had no impact on graft or patient survival. In summary, urologic complications after EBK were common, associated with lower donor weights, occurred early posttransplant, and were often amenable to nonoperative treatment—without adversely affecting survival. We conclude that the higher urologic complication rate after EBK (i) should not prevent increased utilization of small pediatric donor en bloc kidneys for properly selected recipients and (ii) warrants specific discussion with EBK recipients during the preoperative consent process.

1 February 2017 in Transplant Immunology
Verified
Journal Article
Closed access
Gaetano CiancioGaetano Ciancio
Gaetano Ciancio
JGJeffrey Gaynor
Jeffrey Gaynor
GGGiselle Guerra
Giselle Guerra
JSJunichiro Sageshima
Junichiro Sageshima
DRDavid Roth
David Roth
GBGeorge William Burke
George William Burke